Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial (Q44313163)

1 December 2017

title

Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial (English)

1 reference

multicenter clinical trial

1 December 2017

1 reference

1 reference

1 reference

1 reference

T S Maughan

1

1 reference

1 December 2017

R D James

2

1 reference

1 December 2017

D J Kerr

3

1 reference

1 December 2017

J A Ledermann

4

1 reference

1 December 2017

M T Seymour

5

1 reference

1 December 2017

C Topham

6

1 reference

1 December 2017

C McArdle

7

1 reference

1 December 2017

D Cain

8

1 reference

1 December 2017

R J Stephens

9

1 reference

1 December 2017

Medical Research Council Colorectal Cancer Group

10

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

361

1 reference

1 December 2017

issue

9356

1 reference

1 December 2017

page(s)

457-464

1 reference

Attitudes and practice in the management of metastatic colorectal cancer in Britain. Colorectal Cancer Working Party of the UK Medical Research Council

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC. Results of a randomized prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: a Danish Ovarian Study Group trial (DACOVA).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Epirubicin-based chemotherapy in metastatic breast cancer patients: role of dose-intensity and duration of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Prolonged Disease-Free Survival in Hodgkin's Disease with MOPP Reinduction After First Relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Treatment of multiple myeloma with M-2 protocol and without maintenance therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A Mid-Atlantic Oncology Program study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Duration of chemotherapy in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912461-0

7 January 2021

10.1016/S0140-6736(03)12461-0

Identifiers

DOI

1 reference

1 December 2017

1 reference